New HIV shot combo aims to replace daily pills
NCT ID NCT06657885
First seen Jan 17, 2026 · Last updated May 15, 2026 · Updated 21 times
Summary
This study planned to test a two-drug injectable treatment (cabotegravir and lenacapavir) for people with HIV who have tried many medications. The goal was to see if the shots could keep the virus under control without needing daily pills. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV1 INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de nantes- Hotel Dieu
Nantes, France
-
Centre hospitalier François Mitterrand
Dijon, France
-
Centre hospitalier de Tourcoing
Tourcoing, France
-
Chu- Nice Archet
Nice, France
-
Hopital Bichat Claude Bernard
Paris, 75018, France
-
Hopital Necker
Paris, 75015, France
-
Hopital Pitié Salpêtrière
Paris, 75013, France
-
Hopital Saint André
Bordeaux, France
-
Hopital Saint Antoine
Paris, 75012, France
-
Hopital raymond Poincaré
Garches, France
-
Hopiytal Pellegrin
Bordeaux, France
-
Hôpital Franco-Britannique
Levallois-Perret, France
Conditions
Explore the condition pages connected to this study.